Ferroportin 1 (SCL40A1) variant associated with iron overload in African-Americans

Blood Cells, Molecules, and Diseases

Volumn 31, Issue 3, 2003, Pages 305-309

  Beutler, Ernest ^a   Barton, James C ^b   Felitti, Vincent J ^c   Gelbart, Terri ^a   West, Carol ^a   Lee, Pauline L ^a   Waalen, Jill ^a   Vulpe, Chris ^d  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

^b SOUTHERN IRON DISORDERS CENTER   (United States)

^c KAISER PERMANENTE   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FERROPORTIN 1; PROTEIN; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GENE; GENE FREQUENCY; GENE IDENTIFICATION; GENE MUTATION; GENETIC POLYMORPHISM; GENETIC VARIABILITY; HUMAN; IRON OVERLOAD; MACROPHAGE; MAJOR CLINICAL STUDY; MALE; NEGRO; PREVALENCE; PRIORITY JOURNAL; SCL40A1 GENE;

PIERINAE;

EID: 0242724153     PISSN: 10799796     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1079-9796(03)00165-7     Document Type: Article

References (20)

1. Strachan A.S. Haemosiderosis and haemochromatosis in South African natives with a comment on the etiology of haemochromatosis, M.D. Thesis. 1929;University of Glasgow.
2. Gordeuk V., Mukiibi J., Hasstedt S.J., Samowitz W., Edwards C.Q., West G., Ndambire S., Emmanual J., Nkanza N., Chapanduka Z. Iron overload in Africa. Interaction between a gene and dietary iron content. N. Engl. J. Med. 326:1992;95-100.
3. Wurapa R.K., Gordeuk V.R., Brittenham G.M., Khiyami A., Schechter G.P., Edwards C.Q. Primary iron overload in African Americans. Am. J. Med. 101:1996;9-18.
4. Barton J.C., Edwards C.Q., Bertoli L.F., Shroyer T.W., Hudson S.L. Iron overload in African Americans. Am. J. Med. 99:1995;616-623.
5. Pietrangelo A., Montosi G., Totaro A., Garuti C., Conte D., Cassanelli S., Fraquelli M., Sardini C., Vasta F., Gasparini P. Hereditary hemochromatosis in adults without pathogenic mutations in the hemochromatosis gene. N. Engl. J. Med. 341:1999;725-732.
6. Njajou O.T., Vaessen N., Joosse M., Berghuis B., van Dongen J.W., Breuning M.H., Snijders P.J., Rutten W.P., Sandkuijl L.A., Oostra B.A., Van Duijn C.M., Heutink P. A mutation in SLC11A3 is associated with autosomal dominant hemochromatosis. Nat. Genet. 28:2001;213-214.
7. Montosi G., Donovan A., Totaro A., Garuti C., Pignatti E., Cassanelli S., Trenor C.C., Gasparini P., Andrews N.C., Pietrangelo A. Autosomal-dominant hemochromatosis is associated with a mutation in the ferroportin (SLC11A3) gene. J. Clin. Invest. 108:2001;619-623.
8. Fleming R.E., Sly W.S. Ferroportin mutation in autosomal dominant hemochromatosis: loss of function, gain in understanding. J. Clin. Invest. 108:2001;521-522.
9. Njajou O.T., Vaessen N., Oostra B., Heutink P., Van Duijn C.M. The Hemochromatosis N144H Mutation of SLC11A3 Gene in Patients with Type 2 Diabetes. Mol. Genet. Metab. 75:2002;290-291.
10. Devalia V., Carter K., Walker A.P., Perkins S.J., Worwood M., May A., Dooley J.S. Autosomal dominant reticuloendothelial iron overload associated with a 3-base pair deletion in the ferroportin 1 gene (SLC11A3). Blood. 100:2002;695-697.
11. Cazzola M., Cremonesi L., Papaioannou M., Soriani N., Kioumi A., Charalambidou A., Paroni R., Romtsou K., Levi S., Ferrari M., Arosio P., Christakis J. Genetic hyperferritinaemia and reticuloendothelial iron overload associated with a three base pair deletion in the coding region of the ferroportin gene (SLC11A3). Br. J. Haematol. 119:2002;539-546.
12. Beutler E., Felitti V., Gelbart T., Ho N. The effect of HFE genotypes in patients attending a health appraisal clinic. Ann. Intern. Med. 133:2000;329-337.
13. Glatt C.E., DeYoung J.A., Delgado S., Service S.K., Giacomini K.M., Edwards R.H., Risch N., Freimer N.B. Screening a large reference sample to identify very low frequency sequence variants: comparisons between two genes. Nat. Genet. 27:2001;435-438.
14. Lee P.L., Gelbart T., West C., Halloran C., Felitti V., Beutler E. A study of genes that may modulate the expression of hereditary hemochromatosis: transferrin receptor-1, ferroportin, ceruloplasmin, ferritin light and heavy chains, iron regulatory proteins (IRP)-1 and -2, and hepcidin. Blood Cells Mol. Dis. 27:2001;783-802.
15. Lee P.L., Halloran C., West C., Beutler E. Mutation analysis of the transferrin receptor-2 gene in patients with iron overload. Blood Cells Mol. Dis. 27:2001;285-289.
16. Perry G.S., Byers T., Yip R., Margen S. Iron nutrition does not account for the hemoglobin differences between blacks and whites. J. Nutr. 122:1992;1417-1424.
17. McLaren C.E., Li K.T., Gordeuk V.R., Hasselblad V., McLaren G.D. Relationship between transferrin saturation and iron stores in the African American and US Caucasian populations: analysis of data from the third National Health and Nutrition Examination Survey. Blood. 98:2001;2345-2351.
18. Beutler E. ATP. Red Cell Metabolism A Manual of Biochemical Methods. 1984;122-124 Grune & Stratton, New York.
19. Wallas C.H. Elevated red blood cell 2,3-diphosphoglycerate levels in black blood donors. Transfusion. 18:1978;108-112.
20. Manolio T.A., Burke G.L., Savage P.J., Jacobs D.R.J., Sidney S., Wagenknecht L.E., Allman R.M., Tracy R.P. Sex- and race-related differences in liver-associated serum chemistry tests in young adults in the CARDIA study. Clin. Chem. 38:1992;1853-1859.